Your browser doesn't support javascript.
loading
Neutralizing antibodies against adenovirus type 2 in normal and HIV-1-infected subjects: Implications for use of Ad2 vectors in vaccines.
Li, Qianqian; Liu, Qiang; Huang, Weijing; Song, Aijing; Zhao, Chenyan; Wu, Jiajing; Wang, Youchun.
  • Li Q; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Liu Q; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Huang W; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Song A; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Zhao C; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Wu J; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
  • Wang Y; a Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products , National Institutes for Food and Drug Control , Beijing , China.
Hum Vaccin Immunother ; 13(6): 1-8, 2017 06 03.
Article en En | MEDLINE | ID: mdl-28301274
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Vacunas Virales / Infecciones por VIH / Adenovirus Humanos / Infecciones por Adenoviridae / Anticuerpos Neutralizantes / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Portadores de Fármacos / Vacunas Virales / Infecciones por VIH / Adenovirus Humanos / Infecciones por Adenoviridae / Anticuerpos Neutralizantes / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Animals / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2017 Tipo del documento: Article